In back-to-back studies published in Nature, researchers from Purdue University and Columbia University report a naturally ...

Researchers have built a series of CRISPR-based platforms that can switch endogenous genes on and, just as critically, dial ...

Platform combines proprietary AI sequence optimization, novel genetic parts, and lab validation in application-relevant cell models to improve expression and half-life, delivering top candidates in ...

ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today ...

Many RNA programs are under increasing pressure to compress development timelines while ensuring consistent RNA quality and ...

Researchers identified LENG8 as a key RNA quality control protein that prevents defective RNA from leaving the nucleus. By ...

The field of RNA-targeted therapeutics is rapidly evolving, offering groundbreaking opportunities for the treatment of a wide array of diseases ...

In a recent study published in the journal Nature Biotechnology, researchers describe the pA regulator system based on a ribonucleic acid (RNA)-based switch to regulate mammalian gene expression by ...

How do cells ensure that the "blueprints" of genetic information-RNA are accurate and intact before they are exported from ...

Researchers demonstrate that a circular RNA-based AAV platform significantly enhances gene expression in vivo compared with ...